2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$20.47-$0.01 (-0.05%)
Price as of Oct 22, 2026 7:30 PM EDT- $7.0BMarket Cap
- 93.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$20.47-$0.01 (-0.05%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.48 | ||
Change | +$0.36 (+1.81%) | ||
Open | $20.32 | ||
High | $20.58 | ||
Low | $20.20 | ||
Previous Close | $20.20 | ||
Volume | 6,036,678 | ||
30-Day Average Volume | 3,712,595 | ||
1-Week Change | 6.88% | ||
1-Month Change | 0.20% | ||
1-Year Change | 93.67% | ||
3-Year Change | 482.13% | ||
5-Year Change | 253.15% | ||
Fundamentals | |||
Shares Outstanding | 348.3M | ||
Total Assets | $3.8B | ||
Market Cap | $7.0B | ||
Enterprise Value | $9.6B | ||
Period: QTR TTM FY | |||
Revenue | $796.2M | ||
Net Income | $57.7M | ||
Free Cash Flow | -$51.9M | ||
EBIT | $114.1M | ||
EBITDA | $149.0M | ||
Net Working Capital | $1.1B | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 213 | ||
P/E | 112 | ||
PEG | -21 | ||
Price/Free Cash Flow | -135 | ||
Price/Operating Cash Flow | -331 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue